End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jun. 25 | 3Sbio Inc. Announces Board Changes | CI |
May. 29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 7,977 | 100.0 % | 8,637 | 100.0 % | +8.27% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.2
%
| 7,734 | 97.0 % | 8,396 | 97.2 % | +8.56% |
Others
2.8
%
| 243 | 3.0 % | 240 | 2.8 % | -1.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 23-07-02 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Dong Tao Luo
PRN | Corporate Officer/Principal | 48 | 16-02-29 |
Xin Ma
HRO | Human Resources Officer | 58 | - |
Siu Kuen Lai
SEC | Corporate Secretary | 48 | 14-11-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Tian Ruo Pu
BRD | Director/Board Member | 55 | 15-05-31 |
Joo Yeow Ng
BRD | Director/Board Member | 59 | 22-01-20 |
Hoi Ti Yang
BRD | Director/Board Member | 54 | 21-06-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,438,920,412 | 1,769,612,451 ( 72.56 %) | 40,357,688 ( 1.655 %) | 72.56 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
498,883,645 | 95.20% | 1,550,919,498 $ | |
SENSORION 1.35% | 4,055,150 | 1.35% | 3,398,540 $ |
GENSIGHT BIOLOGICS S.A. 2.07% | 2,110,595 | 2.07% | 831,722 $ |
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development No. 3 A1, Road 10
110027, Shenyang
+86 24 2538 6000
http://www.3sbio.com![address 3SBio Inc. (ADR)](https://cdn.zonebourse.com/static/address/42508.png)
Group companies
Name | Category and Sector |
---|---|
Hongkong Sansheng Medical Ltd.
![]() Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. |
Pharmaceuticals: Major
|
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- 1530 Stock
- Stock
- Company 3SBio Inc. (ADR)